Shareholding disclosure
T. Rowe Price Associates, Inc
Declared position
4.95%
Threshold
Crossed upwards
Timeline
Published
18.09.2010
Transaction
09.09.2010
Voting rights breakdown
Voting rights acquired4.95%
Voting rights sold0%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
TAA9F00010
Beneficial owner
T. Rowe Price Associates, Inc
Declared address
T. ROWE PRICE ASSOCIATES, INC, MD 21202, BALTIMORE
T.Rowe Price Associate Inc ("TRPA") is the parent undertaking of T.Rowe Price International, INC ("TRPI"). TRPA and TRPI serve as investment adviser to clients that own 325,214 shares or 4.95% of Newron Pharmaceuticals Spa, including the T.Rowe Price Intarnational Discovery Fund (FUND) which owns 187,861 or 2,86%. As investment adviser, TRPA and TRPI make all adecisions regarding purchase and sale of Newron shares owned by their clients.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open